Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 23354624)

1.

Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction.

Nakai Y, Isayama H, Mukai T, Itoi T, Maetani I, Kawakami H, Yasuda I, Maguchi H, Ryozawa S, Hanada K, Hasebe O, Ito K, Kawamoto H, Mochizuki H, Igarashi Y, Irisawa A, Sasaki T, Togawa O, Hara T, Kamada H, Toda N, Hamada T, Kogure H.

J Gastroenterol. 2013 Nov;48(11):1293-9. doi: 10.1007/s00535-013-0749-6. Epub 2013 Jan 25.

PMID:
23354624
2.

Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study.

Isayama H, Mukai T, Itoi T, Maetani I, Nakai Y, Kawakami H, Yasuda I, Maguchi H, Ryozawa S, Hanada K, Hasebe O, Ito K, Kawamoto H, Mochizuki H, Igarashi Y, Irisawa A, Sasaki T, Togawa O, Hara T, Kamada H, Toda N, Kogure H.

Gastrointest Endosc. 2012 Jul;76(1):84-92. doi: 10.1016/j.gie.2012.02.039. Epub 2012 Apr 5.

PMID:
22482918
3.

Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.

Kitano M, Yamashita Y, Tanaka K, Konishi H, Yazumi S, Nakai Y, Nishiyama O, Uehara H, Mitoro A, Sanuki T, Takaoka M, Koshitani T, Arisaka Y, Shiba M, Hoki N, Sato H, Sasaki Y, Sato M, Hasegawa K, Kawabata H, Okabe Y, Mukai H.

Am J Gastroenterol. 2013 Nov;108(11):1713-22. doi: 10.1038/ajg.2013.305. Epub 2013 Sep 17.

PMID:
24042190
4.

Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer.

Nakai Y, Isayama H, Kogure H, Hamada T, Togawa O, Ito Y, Matsubara S, Arizumi T, Yagioka H, Mizuno S, Sasaki T, Yamamoto N, Hirano K, Tada M, Koike K.

J Gastroenterol Hepatol. 2014 Sep;29(9):1744-9. doi: 10.1111/jgh.12602.

PMID:
24720610
5.

Estimation and comparison of cumulative incidences of biliary self-expandable metallic stent dysfunction accounting for competing risks.

Hamada T, Nakai Y, Isayama H, Togawa O, Kogure H, Kawakubo K, Tsujino T, Sasahira N, Hirano K, Yamamoto N, Ito Y, Sasaki T, Mizuno S, Toda N, Tada M, Koike K.

Dig Endosc. 2014 Mar;26(2):270-5. doi: 10.1111/den.12120. Epub 2013 May 8.

PMID:
23650933
6.

Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents.

Moses PL, Alnaamani KM, Barkun AN, Gordon SR, Mitty RD, Branch MS, Kowalski TE, Martel M, Adam V.

World J Gastroenterol. 2013 Dec 14;19(46):8638-46. doi: 10.3748/wjg.v19.i46.8638.

7.

Prospective evaluation of the partially covered nitinol "ComVi" stent for malignant non hilar biliary obstruction.

Perri V, Boškoski I, Tringali A, Familiari P, Marchese M, Lee DK, Jang SI, Han J, Kim HG, Mutignani M, Onder G, Costamagna G.

Dig Liver Dis. 2013 Apr;45(4):305-9. doi: 10.1016/j.dld.2012.11.001. Epub 2012 Dec 6.

PMID:
23218991
8.

Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstruction.

Togawa O, Isayama H, Tsujino T, Nakai Y, Kogure H, Hamada T, Sasaki T, Yashima Y, Yagioka H, Arizumi T, Ito Y, Matsubara S, Yamamoto N, Sasahira N, Hirano K, Toda N, Tada M, Koike K.

J Gastroenterol. 2013 Nov;48(11):1300-7. doi: 10.1007/s00535-013-0751-z. Epub 2013 Jan 25.

PMID:
23354625
9.

Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention.

Ornellas LC, Stefanidis G, Chuttani R, Gelrud A, Kelleher TB, Pleskow DK.

Gastrointest Endosc. 2009 Oct;70(4):676-83. doi: 10.1016/j.gie.2009.02.012. Epub 2009 Jun 26.

PMID:
19560137
10.

Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases.

Kawakubo K, Isayama H, Nakai Y, Togawa O, Sasahira N, Kogure H, Sasaki T, Matsubara S, Yamamoto N, Hirano K, Tsujino T, Toda N, Tada M, Omata M, Koike K.

Surg Endosc. 2011 Sep;25(9):3094-100. doi: 10.1007/s00464-011-1675-4. Epub 2011 Apr 13.

PMID:
21487869
11.

Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series.

Gómez-Oliva C, Guarner-Argente C, Concepción M, Jiménez FJ, Rodríguez S, Gonzalez-Huix F, Mugica F, Cabriada JL, Rodríguez C, Aguilar CG; Collaborating Group of the COBIWA Register.

Surg Endosc. 2012 Jan;26(1):222-9. doi: 10.1007/s00464-011-1858-z. Epub 2011 Aug 20.

PMID:
21858574
12.

Novel antireflux covered metal stent for recurrent occlusion of biliary metal stents: a pilot study.

Hamada T, Isayama H, Nakai Y, Kogure H, Togawa O, Kawakubo K, Yamamoto N, Ito Y, Sasaki T, Tsujino T, Sasahira N, Hirano K, Tada M, Koike K.

Dig Endosc. 2014 Mar;26(2):264-9. doi: 10.1111/den.12112. Epub 2013 Apr 29.

PMID:
23621525
13.

Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients.

Lee JH, Krishna SG, Singh A, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA.

Gastrointest Endosc. 2013 Aug;78(2):312-24. doi: 10.1016/j.gie.2013.02.032. Epub 2013 Apr 13.

PMID:
23591331
14.

Biliary self-expandable metallic stent for unresectable malignant distal biliary obstruction: which is better: covered or uncovered?

Isayama H, Nakai Y, Kogure H, Yamamoto N, Koike K.

Dig Endosc. 2013 May;25 Suppl 2:71-4. doi: 10.1111/den.12078. Review.

PMID:
23617653
15.

No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis.

Almadi MA, Barkun AN, Martel M.

Clin Gastroenterol Hepatol. 2013 Jan;11(1):27-37.e1. doi: 10.1016/j.cgh.2012.10.019. Epub 2012 Oct 23.

PMID:
23103324
16.

Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction.

Cho JH, Jeon TJ, Park JY, Kim HM, Kim YJ, Park SW, Chung JB, Song SY, Bang S.

Surg Endosc. 2011 Feb;25(2):475-82. doi: 10.1007/s00464-010-1196-6. Epub 2010 Jul 3.

PMID:
20602138
17.

Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial.

Mukai T, Yasuda I, Nakashima M, Doi S, Iwashita T, Iwata K, Kato T, Tomita E, Moriwaki H.

J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):214-22. doi: 10.1007/s00534-012-0508-8.

PMID:
22415652
18.

A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility study.

Isayama H, Kawakubo K, Nakai Y, Inoue K, Gon C, Matsubara S, Kogure H, Ito Y, Tsujino T, Mizuno S, Hamada T, Uchino R, Miyabayashi K, Yamamoto K, Sasaki T, Yamamoto N, Hirano K, Sasahira N, Tada M, Koike K.

Gut Liver. 2013 Nov;7(6):725-30. doi: 10.5009/gnl.2013.7.6.725. Epub 2013 Sep 4.

19.

A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction.

Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, Nakai Y, Yamamoto N, Tada M, Yoshida H, Shiratori Y, Kawabe T, Omata M.

Gut. 2004 May;53(5):729-34.

20.

A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction.

Yoon WJ, Lee JK, Lee KH, Lee WJ, Ryu JK, Kim YT, Yoon YB.

Gastrointest Endosc. 2006 Jun;63(7):996-1000.

PMID:
16733115
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk